Roughly six months after signing a deal for 23,350 square feet, Alnylam Pharmaceuticals already expanded its footprint at 101 Main St. in Cambridge, agreeing to a lease for an additional 48,599 square feet at the 18-story high-rise.
Roughly six months after signing a deal for 23,350 square feet, Alnylam Pharmaceuticals already expanded its footprint at 101 Main St. in Cambridge, agreeing to a lease for an additional 48,599 square feet at the 18-story high-rise.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In